Current status of Japanese HIV-infected patients with
coagulation disorders : coinfection with both HIV and HCV

J 2008

Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV

TATSUNAMI, Shinobu, Junichi MIMAYA, Akira SHIRATA, Jiří ZELINKA, Ivanka HOROVÁ et. al.

Základní údaje

Originální název

Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV

Název česky

Současný stav japonských HIV pacientů s poruchou koagulace: koinfekce HIV i HCV

Autoři

TATSUNAMI, Shinobu (392 Japonsko), Junichi MIMAYA (392 Japonsko), Akira SHIRATA (392 Japonsko), Jiří ZELINKA (203 Česká republika), Ivanka HOROVÁ (203 Česká republika, garant), Jugo HANAI (392 Japonsko), Yukata NISHINA (392 Japonsko), Katsumi OHIRA (392 Japonsko) a Masashi TAKI (392 Japonsko)

Vydání

International Journal of Hematology, Japonsko, Springer, 2008, 0925-5710

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Japonsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.283

Kód RIV

RIV/00216224:14310/08:00027284

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000259910200012

Klíčová slova anglicky

Hemophiliacs; Coagulation disorders; HIV; HCV; Survival; Surveillance

Štítky

Coagulation disorders, HCV, Hemophiliacs, HIV, surveillance, survival

Příznaky

Recenzováno

Změněno: 23. 6. 2009 10:26, Mgr. Jiří Zelinka, Dr.

Anotace

ORIG CZ

V originále

We herein report on the current status of Japanese HIV-positive patients with coagulation disorders, primarily hemophilia, based on the national survey of 31 May 2006. The total number of registered patients was 1,431 (Hemophilia A 1,086; Hemophilia B 325; von Willebrand disease 8; others 12), and 604 of these patients were deceased by 31 May 2006. The survival rate after the beginning of 1983 was evaluated by the Kaplan-Meier method. The total number of surviving patients was 827, and the survival rate on 31 May 2006 was 55.7 +- 1.4%. Among the 827 surviving patients, HCV antibody was observed in 740, was negative in 16, and was not reported in 71 patients. Thus, the prevalence of HCV infection was 98% in the surviving patients based on the presence of HCV antibody. Among the 604 deceased patients, liver disease was reported as a cause of death in 149 cases (25%), and infection with HCV was reported as the possible cause of liver disease in 120 cases (20%). After 1997, 63 cases among the subtotal of 148 deaths had critical hepatic disease that originated from HCV infection, which accounted for 43% of the subtotal. The cumulative rate of patients who received interferon therapy was 32%. Interferon therapy should be prescribed more frequently to HIV-positive patients with coagulation disorders in order to realize the survival benefits, although clinicians should be aware of side effects and toxicities.

Česky

Je zdo podám výzkum stavu japonských HIV pacientů s poruchou koagulace.

Návaznosti

LC06024, projekt VaV

Název: Centrum Jaroslava Hájka pro teoretickou a aplikovanou statistiku

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Centrum Jaroslava Hájka pro teoretickou a aplikovanou statistiku

Citovat

TATSUNAMI, Shinobu, Junichi MIMAYA, Akira SHIRATA, Jiří ZELINKA, Ivanka HOROVÁ, Jugo HANAI, Yukata NISHINA, Katsumi OHIRA a Masashi TAKI. Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV. International Journal of Hematology. Japonsko: Springer, 2008, roč. 88, č. 3, s. 304-310. ISSN 0925-5710.

@article{807337,
   author = {Tatsunami, Shinobu and Mimaya, Junichi and Shirata, Akira and Zelinka, Jiří and Horová, Ivanka and Hanai, Jugo and Nishina, Yukata and Ohira, Katsumi and Taki, Masashi},
   article_location = {Japonsko},
   article_number = {3},
   keywords = {Hemophiliacs; Coagulation disorders; HIV; HCV; Survival; Surveillance},
   language = {eng},
   issn = {0925-5710},
   journal = {International Journal of Hematology},
   title = {Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV},
   url = {http://springerlink.com/content/yx74v732v6843j2g/},
   volume = {88},
   year = {2008}
}

TY  - JOUR
ID  - 807337
AU  - Tatsunami, Shinobu - Mimaya, Junichi - Shirata, Akira - Zelinka, Jiří - Horová, Ivanka - Hanai, Jugo - Nishina, Yukata - Ohira, Katsumi - Taki, Masashi
PY  - 2008
TI  - Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV
JF  - International Journal of Hematology
VL  - 88
IS  - 3
SP  - 304-310
EP  - 304-310
PB  - Springer
SN  - 09255710
KW  - Hemophiliacs
KW  - Coagulation disorders
KW  - HIV
KW  - HCV
KW  - Survival
KW  - Surveillance
UR  - http://springerlink.com/content/yx74v732v6843j2g/
N2  - We herein report on the current status of Japanese HIV-positive patients with coagulation disorders, primarily hemophilia, based on the national survey of 31 May 2006. The total number of registered patients was 1,431 (Hemophilia A 1,086; Hemophilia B 325; von Willebrand disease 8; others 12), and 604 of these patients were deceased by 31 May 2006. The survival rate after the beginning of 1983 was evaluated by the Kaplan-Meier method. The total number of surviving patients was 827, and the survival rate on 31 May 2006 was 55.7 +- 1.4%. Among the 827 surviving patients, HCV antibody was observed in 740, was negative in 16, and was not reported in 71 patients. Thus, the prevalence of HCV infection was 98% in the surviving patients based on the presence of HCV antibody. Among the 604 deceased patients, liver disease was reported as a cause of death in 149 cases (25%), and infection with HCV was reported as the possible cause of liver disease in 120 cases (20%). After 1997, 63 cases among the subtotal of 148 deaths had critical hepatic disease that originated from HCV infection, which accounted for 43% of the subtotal. The cumulative rate of patients who received interferon therapy was 32%. Interferon therapy should be prescribed more frequently to HIV-positive patients with coagulation disorders in order to realize the survival benefits, although clinicians should be aware of side effects and toxicities.
ER  -

TATSUNAMI, Shinobu, Junichi MIMAYA, Akira SHIRATA, Jiří ZELINKA, Ivanka HOROVÁ, Jugo HANAI, Yukata NISHINA, Katsumi OHIRA a Masashi TAKI. Current status of Japanese HIV-infected patients with coagulation disorders : coinfection with both HIV and HCV. \textit{International Journal of Hematology}. Japonsko: Springer, 2008, roč.~88, č.~3, s.~304-310. ISSN~0925-5710.

Podrobný výpis o publikaci